BEIJING (AFP) - China has reported its first human case of bird flu in six months, but the farmer who fell ill made a full recovery and the World Health Organisation said there was no cause for alarm.
China BioPharma (OTC:CBPC) - BIRD FLU VACCINE TESTING (has copy of deadly H5N1 virus)
Avian (“Bird Flu”) H5N1 Virus – By February 2004, the avian or “bird” flu spread across 10 countries in Asia and caused dozens of deaths in Thailand and Vietnam. In China, the bird flu affected more than half of all provinces and territories. CBPC stands to be a major player in creating and mass-producing a vaccine for a potential pandemic bird flu outbreak. In June 2006, China Biopharma received a copy of the H5N1 virus (a deadly virus transmitted from bird to human), and has begun animal testing on a vaccine.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.